Skip to main content
Iranian Journal of Microbiology logoLink to Iranian Journal of Microbiology
. 2023 Apr;15(2):325–335. doi: 10.18502/ijm.v15i2.12485

Effect of new methionine-based ionic liquid on the CDR1 and CDR2 gene expression on sensitive and resistant strains of Candida albicans

Mona Eslami 1, Ali Ezabadi 2,*, Mansour Bayat 1, Behin Omidi 3, Pejman Mortazavi 1
PMCID: PMC10183073  PMID: 37193238

Abstract

Background and Objectives:

Previous researchers showed the antimicrobial ability of ionic liquids (ILs) on different infective agents. ILs can dissolve organic components, especially DNA molecules. Among synthesized eight binary ILs mixtures, we have chosen ([Met-HCl] [PyS]) IL for determining the antifungal ability of IL against Candida albicans cells.

Materials and Methods:

Well diffusion assay, chrome agar and Germ tube tests were used to detect the Candida samples. PCR, real-time-PCR, and flow cytometry tests were performed to determine the IL's rate of toxic ability.

Results:

Well diffusion assay revealed the diameters of the growth inhibition zones were the largest in IL with methionine and Proline amino acids. Minimum inhibitory concentration (MIC) and the Minimum fungicidal concentration (MFC) tests showed that they inhibited the growth of the C. albicans at a range from 250 μg/ml for sensitivity and 400 μg/ml for resistance, MIC average of all samples were 341.62 ± 4.153 μg/ml. IL reduced the expression of CDR1 and CDR2 the genes encoded by the major protein of ABC system transporter by 2.1 (P= 0.009) and 1.2 fold (P= 0.693), revealed by PCR and real time-PCR. In the flow cytometry test, there were increasing dead cells after treating with the ([Met-HCl] [PyS]) even in the most resistant strain.

Conclusion:

The novel IL was effective against the most clinical and standard C. albicans.

Keywords: Ionic liquid, Candida albicans, Candidiasis, Antifungal agents, Methionine

INTRODUCTION

This study aims to research and produce a healthy ionic liquid for the body that is effective on Candida albicans strains and prevents its growth. Ionic Liquids (ILs), a deceptive material, are composed of cations and anions. Firstly, ILs were applied in 1914 as non-volatile electrolytes for batteries (1). ILs have many interesting properties, including powerful conductivity of cations or anions (2), low flammability (3), adequate thermal stability (4), adjustable polarity, being solvent in various biochemical substances (5), little moisture pressure, and low melting point (6). Due to their favorite effects, ILs were operated in biochemical processes, organic molecular synthesis (7), absorption of CO2, SO2 (8), and extraction from nanoparticles (9). Two common ionic liquids, ammonium or phosphonium-based, could produce proper bioactive anticancer, antimicrobial, and antiparasitic drugs (10, 11). Selection and modification of the anion and cation of the quaternary ammonium-based ILs with positive nitrogen could form tune physical properties, such as good melting, water-solubility, rate of conduction, and viscosity (12). Antimicrobial activity of the alkyl group on the different infective agents has been previously shown (13, 14). ILs can dissolve organic components, especially DNA molecules. ILs have low vapor potency leads to reuse repeatedly, unlike volatile components. A report showed that the 3rd descendant ILs could increase the ability to deliver active drug ingredients through increased solubility of its absorption. ILs carrier proteins and amino acids by developing acceptors with strong hydrogen bonds. Recent technology of ILs assessed on the ammonium-based salts is hydrophobic and can induce antimicrobial behavior. An aniline based ionic liquid could kill microorganisms (15). Candida albicans is a commensal microorganism in human and animal mucosal flora. They can induce candidiasis, especially in immunosuppressed patients. After immunosuppressing, antibacterial therapy and venous injection by polluted catheter are the other causes of Candida spp. overgrowth (16). Changing ions in ionic liquids may alter their chemical and physical properties and create a specific function. One study showed that the northern hybridization technique could detect the expression of two types of genes that encode pumps with efflux ability named the CDR and MDR in C. albicans. These genes are related to efflux pumps during biofilm growth. Mutation in the genes related to the efflux pumps could prepare some conditions that lead to the susceptibility of C. albicans to antifungal drugs. The mutants harboring a deletion of CDR1, CDR2, or MDR1 increase susceptibility to fluconazole in planktonic form. Candida biofilm development and resistance could be with various mechanisms that may involve different molecular factors (17).

Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful technique to analyze the chemical purity and structures of organic compound. This technique, which includes 1H and 13C NMR, can be used to picture the structure of the molecules. The 1H NMR could define the number and types of hydrogen atoms of an organic molecule. The 13C NMR could determine the number of carbon atoms. Flow cytometry is an automated technique for defining and evaluating the dimensions of single cells and their chemical aspects within a cell population. This technology can detect different fungi species. Flow cytometry detects various fungi cells and micro-colonies. Live, fixed, or non-fixed dead fungi cells stained with fluorescent (18). This study aimed to synthesize methionine-based ionic liquids and their preventing effects on the growth of Candida spp. collected from immunocompromised patients and a standard strain. This study aimed to investigate the effect of a new ionic liquid with methionine chloride and pyridinium sulfonate ([Met-HCl] [PyS]) on C. albicans growth. All chemical reagents and solvents were commercially available and used without further purification. The 1H and 13C NMR spectra were recorded on an INOVA 500 MHz using DMSO-d6, CDCl3, or D2O as a solvent and calibrated with tetramethylsilane (TMS) as the internal reference. IR spectra were on a JASCO FT-IR410 spectrometer with KBr, shown in Fig. 1.

Fig. 1.

Fig. 1.

FT-IR spectrum of ([Met-HCl] [PyS]).

MATERIALS AND METHODS

Providing pre materials

Modifying the cations and anions in ionic liquids lead to a proper specific function (19).

Experimental procedure: ([Met-HCl] [PyS]) synthesis

Pyridine-N-sulfonic acid was synthetized by the method reported in the previous literature. Then, methionine (9.5 mmol) was added in small portions to a mixture of Pyridine-N-sulfonic acid (0.977g, 5 mmol) in deionized water (20 mL) over 30 min, and the reaction mixture was stirred for 24 h at room temperature. Then the solvent was removed by rotary evaporator under reduced pressure, and the obtained IL was washed with ether (3×20 mL) and dried under vacuum (12, 20).

Candida samples, Germ tube forming, and CHROMagar

We took 70 samples from the oral cavity and skin of immunocompromised patients with candidiasis. Then cultured those on Sabouraud dextrose agar containing chloramphenicol (Armanbiotech, Iran), incubated at 35°C for 24–48 h aerobically. Candida isolates were analyzed macroscopically by direct observation, germ tube forming, and CHROMagar medium of Candida, For isolation and differentiation of major clinical-significant Candida species. Candida albicans produce a green color in CHROMagar (21, 22).

Antifungal susceptibility test

The resistance and sensitivity of C. albicans strains against amphotericin B, fluconazole, itraconazole, and ketoconazole (HiMedia Company) were investigated by the Kirby-Bauer method, based on standard CLSI M100-2018 (Performance Standards for Antimicrobial Susceptibility Testing) (21).

Well diffusion assay

The antifungal activity of IL was determined by the agar well diffusion test based on standard CLSI M44-A2 (Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts). The C. albicans strains were cultured on Sabouraud Dextrose Agar plates with a sterile swab moistened with the fungal suspension at 0.5 McFarland. Subsequently, wells of 8 mm diameter were punched into the agar medium and filled with 100 μl (25 mg/ml) of the saturated ([Met-HCl] [PyS]) IL and some ILs composed of other amino acids, allowed to diffuse at room temperature for 2 h. The plates were incubated at 37°C for 24 h. After incubation, the diameters of the growth inhibition zones were measured (23).

Determination of MICs

According to CLSI M27-A3 (Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts) the microdilution method, determine the ionic liquid's minimum inhibitory concentration (MICs). 100 ml of RPMI 1640 add to any wells then the ionic liquid was added, and different concentration of ILs was made by serial dilution method (2, 4, 8, 16, 32, 64, 128, 256, and 1024 mg/L), the strain suspension (1.5×108 CFU/ml) was added and incubated at 37°C for 48 h. The C. albicans in the culture medium were the negative control. Medium culture in 100 ml of the ionic liquid was a positive control. The phenomena of trailing were clarified as reducing turbidity compared to positive control but regularly attending in all wells; the suspension needed to become optically clear (2426). The paradoxical growth was characterized as the growth of microorganisms at highly raised concentrations, further the obvious MIC (2729).

Determination MFC

MFCs were estimated by pouring 0.1ml from MIC (without growth) wells onto SDA plates. The MFC was the lowest IL concentration, destroying≥ 99.9% of cells. The positive controls were the Fluconazole solution (30).

Detection of CDR1 and CDR2 with PCR method

The PCR detected the gene expression of the CDR1 and CDR2 in C. albicans strains. The SINACLON DNA Extraction kit (Tehran Cavosh Clon-Iran) was used for extracted all the DNA samples from the C. albicans strain in Tehran, Iran. Absolute 20 μl volume including 2 μl water, 10pmol/μl forward primer (sequence primers present in Table 1), 10pmol/μl reverse primer, 100 ng DNA, and 10 μl Master mix 2× were used to perform the PCR. Predenaturation at 95°C for 3 min started the reaction followed by 35 cycles. The process was denaturation at 95°C for 30 sec, annealing at 57°C for 30 sec, extension at 72°C for 30 sec, and the last step of reaction at 72°C for 5 min. The base design of the primers used for this step to investigate the presence of the gene from clinical samples of C. albicans originated from research and synthesized by SINA COLON.CO, Iran (17).

Table 1.

GenBank accession to primer sequences of CDR1 and CDR2

Gene GenBank accession number Product length (base pairs) Primer sequences
CDR1 X77589 93 Forward: 5′-TGTGTACTATCCATCAACCATCAGC-3′
Revers: 5′-CACCAAAATAAGCCGTTCTACCA-3′
CDR2 U63812 125 Forward: 5′-TGGCAAACAATCCAACAATACA-3′
Revers: 5′-AATCAAGGGAATAGATGGGTCA-3′

Determination of the expression of the CDR1 and CDR2 via Real Time RT PCR method: RNA extraction and purification

Total RNA samples from clinical isolates of C. albicans strain and C. albicans ATCC 10231 were GTP RNA extracted (RNA Isolation Kit-S-1010-1, Dena Zist Asia, Iran). In a 2 μl tube, 1×106 fungal cells collected by centrifugation (2 min at 10000 rpm) were placed, and the supernatant was removed by pipetting. The pellet was resuspended in freshly prepared lysozyme. The tube was incubated at 37°C for 5 min. 400 μl of lysis solution was added, following the laboratory protocol. 300 μl of the precipitating solution was added and inverted for 10 min. Then the solution was transferred into a spin column by pipetting and centrifuging the tube at 13000 RPM for 1 min. After discarding the supernatant, 500 microliters of washing Buffer1 was added and centrifuged. After discarding the supernatant, 750 microliters of washing buffer2 was added. The supernatant was discarded after centrifugation, and the RB column was placed in a new collection tube for complete drying and centrifuged for 3.5 minutes at 12,000 rpm at 4 degrees Celsius. The RB column was placed in the elution tube, and 50 microliters of nuclease-free water were added to the center of the RB column. After one minute, centrifugation was performed for 1.5 minutes with a rotation of 12000 rpm at 4 degrees Celsius, and RNA was kept at minus 70 degrees Celsius. Thereafter 2 μl buffer10×, 2 μl M-MLV reverse transcriptase (100unit) was poured and nuclease-free water was in the wells. The protocol was initiated by mixing the agents well and centrifuging briefly before pipetting. Then we added 10 μg total RNA1, Oligo (dT) 18 Primer (18-mer oligonucleotide with 5′- and 3′-hydroxyl ends), 1 μl dNTP 10mM, and nuclease-free water (top up to 10 μl). 10μl synthesized mix cDNA was incubated at 42°C for 60 min and then incubated for 5 min at 85°C to stop the reaction.

Operative process of the Real-Time RT PCR

0.8 micromole designed primers used in this presentation were according to the previous study (31). The content of the 20 μl provided solution was 50 ng of cDNA, 12.5 μl of 2× SYBR Green, 1 μl of each primer, and 10 μl of ddH2O, followed by putting the mixed solution in the 95°C for 60 sec, 95°C-15 sec for denaturation, 55°C-15 sec for annealing, 72°C-45 sec for extension, and the final extension for 72°C-45 sec. ACT1 (F:ATTATATGTTTAGAGGTTGCTGCTTTGG

R: CAATTCGTTGTAGAAGGTATGATGCC), housekeeping, was designed as an internal reference gene. Calculation of the relative target-gene expression was a fold change of 2−ΔΔCT value.

Then, we performed the final evaluation to clear the preventing effect of the newly synthesized ([Met-HCl] [PyS]) IL on the CDR1 and CDR2 genes expression by Real Time RT PCR. The primer sequences used for this evaluation was shown in Table 1. The reaction was performed in an EcoTM Real-Time model device (Illumina biotech company, USA). For amplification in each well (48-well plate), a 20-microliter mixture of nuclease-free water (10 μl), Cybergreen reaction mixture (6 μl), template DNA (2 μl), and specific primers (1 μl), for each gene was prepared. The time and temperature program of the reaction was carried out in three stages: the first stage in one cycle to activate the hot start monopolymerase enzyme and initialize the template DNA at a temperature of 95°C for 3 minutes; the second step alternately during 40 cycles of annealing at 95°C for 5 seconds and joining and extension at 60°C for 20 seconds; The third step is applying a cycle with a temperature of 95°C for 15 seconds, 60°C for 30 seconds and 95°C for 15 seconds to draw a curve.

Flow-cytometry test

Flow cytometry was used to check the ability of the synthesized ionic liquids to kill fungal cells. For this purpose Fresh cultures of Candida, strains Suspension (0.5 McFarland) was prepared and treated with MIC concentration of ILs. After incubation for 12 hours, the cells were washed with PBS and fixed with 70% ethanol overnight at 4°C. The cells were treated with 200 μg/ml of RNase A and mixtured then incubated for 2 hours at 37°C. For DNA staining, 50 μg/ml of propidium iodide (PI) was added and incubated for 1 hour at 4°C in the dark, then studied with Flow cytometric analyzer.

Statistical analysis

The data analysis using One-way ANOVA and the Tukey test, in which p≤ 0.05 were considered statistically significant. All experiments results were reported as mean ± standard deviation (n=3) and Spss 26 was used. The difference in gene expression was calculated using GENE6 software and the graphs were drawn by Graph Pad Prism 8.

RESULTS

Characterization of the new synthesized IL

This item was confirmed by FT-IR, 1H NMR, and 13C NMR. The IR spectrum of the IL is shown in Fig. 1. The broad band at 2500–3400 cm−1 arises the overlaid NH3+ stretching band and the O-H stretching. The vibrational band at 1740 cm−1 can be assigned to the C=O bond. The absorptions at 1636 and 1576 cm−1 are characteristic of carbon-carbon aromatic stretching vibrations. The bands at 1178 and 589 cm−1 can be assigned to the vibrational mode of the S-O band of the SO3 group.

The 1HNMR of the IL gave signals in D2O. The IL contained five aromatic hydrogens that belonged to the pyridine ring that appeared at 8.0 ppm (t, 2H), 8.5 ppm (t, 1H), and 8.7 ppm (d, 2H). The CH3 group of amino acid gives a singlet at 2.02 ppm. Also, CH2 of the c-Carbone varied between 2.0 and ~2.20 ppm. The methylene hydrogens of b-Carbone and methine hydrogen of a-Carbone appear as triplets in 2.60 and 4.1 ppm. The 13C NMR displays the signals for the eight carbon atoms in the IL. The chemical shifts at 143.7, 148.6, and 151.9 ppm were assigned to the pyridine ring. Also, the chemical shift at 185.1 ppm can be attributed to the carboxyl group of the amino acid moiety of the IL. The chemical shifts that appeared at 24.0, 28.3, 53.4, and 59.2 ppm can be related to the carbons of the other carbon atoms of the amino acid moiety of the IL.

CHROMagar test

70 samples from people suffering from candidiasis were used, and after culturing on chrome agar medium and separating colonies that were green (as shown in Fig. 2a), and performing germ tube test (as shown in Fig. 2b), 50 samples of Candida albicans were identified, and the other tests were performed on these 50 strains.

Fig. 2.

Fig. 2.

Chrome agar medium (a) and Germ tube test (b). Yellow arrow: Candida pigmentation; Black arrow: germ tube formation.

All positive germ tube tests preserved using the horse serum presented filamentous mycelium, a morphological transition. Both tests revealed fifty of all seventy Candida samples were recognized as C. albicans strain. Fig. 4b indicates these results.

Fig. 4.

Fig. 4.

Diagram of MIC and MFC determination of clinical samples after treatment with ([Met-HCL] [Pys]).

Antibiogram test

Table 2 shows the effect of four antifungal drugs on Candida strains. Results comparing with the standard table of drugs and sensitive and resistant strains were identified. Among these four drugs, fluconazole showed the best fungicidal activity on the C. albicans strains (Table 2).

Table 2.

Antibiogram of antifungal drug against the C. albicans strains.

Drug Inhibition Zone (mm) Sensitive Inhibition Zone (mm) Resistance
Fluconazole 30.2±2.13 10.9 ± 0.943
Amphotericin B 29.4±1.35 10.8 ± 0.87
Itraconazole 18.9±0.83 10.7 ± 1.18
Ketoconazole 16.41±0.57 10.6 ± 0.48

Well diffusion assay of ILs on C. albicans

The antifungal activity of the newly synthesized ionic against the C. albicans strains and liquids has been shown in Fig. 5. The average inhibition zone of IL by methionine was 32 ± 0.43, IL by proline was 26 ± 1.7, IL by pyridine SO3H was 25 ± 0.5, IL by serine was 22 ± 1, IL by leucine was 22 ± 1.34, IL by alanine was 20 ± 1.29, IL by valine was 25 ±2.05, IL by glycine was 13 ± 1.5 and IL by phenylalanine was 0.0 ± 0. Comparing the effect of the newly synthesized ILs with some amino acids, the diameters of the growth inhibition zones were the largest in IL with methionine and proline amino acids (Fig. 3).

Fig. 5.

Fig. 5.

The percent of expression of the CDR1 and CDR2.

Fig. 3.

Fig. 3.

The growth inhibition zones of the eight new synthesized ILs on C. albicans strains.

MIC and MFC test of new synthesized ILs on C. albicans

In this research, eight new ionic liquids were synthesized using different amino acids, among them the ([Met-HCl] [PyS]) was shown best and most powerful result to inhibit the growth of the Candida albicans strains. MIC range of the ([Met-HCl] [PyS]) was 250 μg/mL for sensitivity and 400 μg/mL for resistant strains (present in Fig. 4). The average MIC was 341.62 ± 4.153 μg/mL. Fig. 4 shows the results of the MFC for all samples. The average of MFC was 587.6 ± 6.59 μg/mL.

PCR evaluation of CDR1 and CDR2 expression

Before exposure to IL, the fifty strains of C. albicans were studied for the expression of CDR1 and CDR2 using the PCR method (Fig. 5). Then among fifty clinical isolates of C. albicans, 45 numbers (90%) expressed CDR1 while 44 numbers (88%) expressed the CDR2 genes. We chose two samples of numbers 4 and 30 to investigate the rate of the ([Met-HCL] [Pys]) on the expression of the CDR1 and CDR2 (Fig. 5).

Real-Time PCR evaluation of CDR1 and CDR2 rate expression

Evaluating the rate of CDR1 and CDR2 expression after the exposure to the ([Met-HCl] [PyS]) IL on the number of 4 and 30 selected isolates by the q Real-Time PCR method. These isolates were selected because of their resistance and sensitive abilities. The results showed a decrease in the expression and fold changing of the proteins (Fig. 6 and Table 3).

Fig. 6.

Fig. 6.

The q RT-PCR; Comparing the fold change of CDR1 and CDR2 in IL treated group and untreated (control) group. **P= 0.009; ns: Non-significant.

Table 3.

Fold change of CDR1 and CDR2 in treated with ([Met-HCL] [Pys]) and untreated groups.

brpA (untreat) brpA (treat) Diff [brpA (untreat, treat)
CDR1 3.02 3.3 −0.28
CDR2 4.37 4.645 −0.275
count 2 2 2
Mean 3.69 3.97 −0.27
STDEV 0.954 0.951 0.0035
P-Value 0.0057
Confidence Level(CI) 94%
Difference (A-B log scale) −0.277
Fold Change −1.43

The amount of fold change for the brpA gene is equal to −1.43, which indicates that this gene has decreased by 1.43 times in the treated group compared to the untreated group. The Count row indicates the number of examined samples. The Mean row indicates the average of two samples. P≤ 0.05

According to data presented in Table 2, there is about a 2 (2.1322) fold change reduction in CDR1 gene expression in IL-treated groups. In contrast, the change of CDR2 was 1.27 fold nonsignificant (P= 0.693). The decrease in fold change of the CDR1 gene showed that the novel IL had a significant inhibiting effect on the CDR1 gene expression (P= 0.009).

Flow cytometry test

Among fifty samples, we selected three numbers of 4, 8, and 7 as sensitive, resistant, and moderate isolates according to the growth inhibition diameter zones (Fig. 7). The ([Met-HCl] [PyS]) IL showed the fungicide ability in all three selected isolates, which means the novel ([Met-HCl] [PyS]) IL showed a superior effect on inhibiting C. albicans growth resulting in increasing of dead cells of the fungus. Even in the most resistant isolate (number 8), there was an increase in dead cells compared to the control (P=0.39960). The controls in this test were live Candida albicance.

Fig. 7.

Fig. 7.

Flow cytometry revealed the effect of the IL on viability of C. albicans isolates from clinical samples.

DISCUSSION

Candida albicans is the most causative agent of candidiasis, especially in critical and immunocompromised patients. One of the challenges in developing new antifungal drugs is the overexpression of the CDR1 and CDR2 efflux pumps that cause resistance against the common antifungal medications (17). Emerging ILs with unique properties of the elongated against the fungal agents, lead the researchers to apply them as new safe administrations against fungi (17). Some of the investigators demonstrated the antimicrobial function of various ionic liquids (12, 32). Imidazolium containing hexadecyl, the ionic liquid, can prevent the growth of microorganisms and Candida species (33, 34). The vast biological activity of ILs depends on thermal stability, charge electronegativity, alkyl agents, and size. ILs can interact between changes in the biomolecules (35, 36). Biologically active agents or molecules are the most important fields of ILs to be studied (32, 37). In this study, eight (n= 8) newly designed ILs were designed with 1-sulfopyridinium chloride as the precursor and eight (n=8) various amino acids and properly characterized using spectroscopic techniques. Novelty is the key feature of the protocol to synthesize the ILs used in this study. According to these findings of MIC and vast inhibition zone around the C. albicans strains, there are the best antifungal ability in the ([Met-HCl] [PyS]) compared to the other ILs synthesized in this study. So the rest of our experiments were performed using ([Met-HCl] [PyS]) IL. Some researchers synthesized the diethanolamine Lactic IL successfully, by replacement of halogenated ion fluid. They confirmed this IL using the Fourier transform infrared (FT-IR) spectra and nuclear magnetic resonance (NMR) spectroscopy. We synthesized the novel ILs successfully and characterized them using FT-IR and NMR spectra (38). The other researcher applied a series of 1-alkylquinolinium bromide against clinically relevant microbes such as C. albicans. They reported that tested ILs had broad-spectrum antimicrobial activity against fungi and Gram-positive bacteria (39). In this presentation, we evaluated the antifungal activity of all eight novel ILs similar to the previous study (20). Comparing the efficiency of the novel ([Met-HCl] [PyS]) MIC (MIC <1 mg/mL) of our study with previously reported by some researchers with 3-Choropropanoic acid base IL on the C. albicans strains (ATCC, American Type Culture Collection: MIC >169 μg/mL; ATCC: MIC >338 μg/mL) showed a better antifungal activity of our ([Met-HCl] [PyS]) novel IL (40). The work of Yang et al. (2021) exhibited the antimicrobial activity of imidazolium chloride-based ILs + tetracycline/doxycycline enhanced toxic activity against both bacteria and yeast. These antibiotics inhibit protein synthesis. But they had limited efficacy due to antibiotic resistance. Interestingly, we found the complementarity effect and efficient antifungal activity of ([Met-HCl] [PyS]) against C. albicans (41). In the present study, after treatment with the novel ([Met-HCl] [PyS]), the zone inhibition diameter was 32 ± 0.43 mm exhibited a better effect on inhibiting C. albicans growth. CDR1 and CDR2 are important glycoprotein structures in fluconazole resistance in Candida species (42). Fructose administration over than efficient diet could induce fluconazole resistance in C. albicans via the activation of CDR1 and MDR1 transporters (43). Upregulations of multidrug efflux pumps to belong to the ATP-binding cassette transporters superfamily controlled by CDR1/CDR2 proteins were involved in most C. albicans fluconazole-resistant strains (44). So in the present study, we investigated the role of the novel ([Met-HCl] [PyS]) on the expression level of these two proteins. This study showed a significant reduction of the CDR1 expression and fold change from 1.000 to 0.469 in non-treated and treated strains (P=0.009). This data showed that the ([Met-HCL] [Pys]) could suppress the expression of the protein CDR1 significantly. Kaempferol (natural flavonol) can inhibit CDR1 expression more than CDR2 in fluconazole-resistant C. albicans strains (45). Similarly, our data showed a reduction in the fold change of the CDR2 expression from 1.000 to 0.787 in non-treated and treated samples, which was not significant (P=0.69). Anti-fungal abilities of ILs have earned attention in research because of the different chemical processes. In a paper, flow cytometry was used to demonstrate the cytotoxicity of methyl alkyl imidazolium-based ILs in Saccharomyces yeast (46). Flow cytometry could detect and evaluate the quantitation of yeast death and viability (47). Its cytotoxicity evaluation was dependent on dose and time (48). The main advantage of flow cytometry over other methods is the synergy of detection speed and accuracy. This means that a large number of cells can be identified in terms of viability or function and morphology (18). The results of the flow cytometry test of the present study confirmed the effect of the novel ([Met-HCl] [PyS]) IL on increasing the dead cells of C. albicans after treatment. Each method used in this study is evidence of the antifungal effect of our new synthesized IL on C. albicans strains.

CONCLUSION

This investigation revealed the antifungal ability of the ([Met-HCl] [PyS]) IL against C. albicans strains. ([Met-HCl] [PyS]) can be a candidate for treating candidiasis with effective cytotoxicity to resistant Candida cells.

ACKNOWLEDGEMENTS

The authors would like to express their gratitude to the Department of Chemistry, Islamic Azad University, Central Tehran Branch and Department of Veterinary, Islamic Azad University, Science and Research Branch.

REFERENCES

  • 1.Fang Z, Zheng X, Li L, Qi J, Wu W, Lu Y. Ionic liquids: emerging antimicrobial agents. Pharm Res 2022; 39: 2391–2404. [DOI] [PubMed] [Google Scholar]
  • 2.Zhang Q, Cai S, Zhang W, Lan Y, Zhang X. Density, viscosity, conductivity, refractive index and interaction study of binary mixtures of the ionic liquid 1–ethyl–3–methylimidazolium acetate with methyldiethanolamine. J Mol Liq 2017; 233: 471–478. [Google Scholar]
  • 3.Wu H-B, Zhang B, Liu S-H, Chen C-C. Flammability estimation of 1-hexyl-3-methylimidazolium bis (trifluoromethylsulfonyl) imide. J Loss Prev Process Ind 2020; 66: 104196. [Google Scholar]
  • 4.Petriček S. Pyridin-2-one in complexes, cocrystals and an ionic liquid. Syntheses, structures and thermal stability. J Mol Struct 2022; 1260: 132790. [Google Scholar]
  • 5.Mero A, Guglielmero L, D'Andrea F, Pomelli CS, Guazzelli L, Koutsoumpos S, et al. Influence of the cation partner on levulinate ionic liquids properties. J Mol Liq 2022; 354: 118850. [Google Scholar]
  • 6.Plakia A, Koulocheris V, Louli V, Voutsas E. Vapor-liquid equilibrium of acid gases with imidazolium-based ionic liquids using the UMR-PRU model. CTTA 2022; 8: 100097. [Google Scholar]
  • 7.Guo Y, Wang Q, Ren S, Zhang M, Peng X. Numerical investigation on the wave transformation in the ionic liquid compressor for the application in hydrogen refuelling stations. Int J Hydrogen Energy 2023; 10.1016/j.ijhydene.2022.12.335. [DOI] [Google Scholar]
  • 8.Guglielmero L, Mezzetta A, Pomelli CS, Chiappe C, Guazzelli L. Evaluation of the effect of the dicationic ionic liquid structure on the cycloaddition of CO2 to epoxides. J CO2 Util 2019; 34: 437–445. [Google Scholar]
  • 9.Singh V, Amirchand KD, Gardas RL. Ionic liquid-nanoparticle based hybrid systems for energy conversion and energy storage applications. J Taiwan Inst Chem Eng 2022; 133: 104237. [Google Scholar]
  • 10.Shamshina JL, Rogers RD. Are myths and preconceptions preventing us from applying ionic liquid forms of antiviral medicines to the current health crisis? Int J Mol Sci 2020; 21: 6002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Santos MM, Alves C, Silva J, Florindo C, Costa A, Petrovski Ž, et al. Antimicrobial activities of highly bioavailable organic salts and ionic liquids from fluoroquinolones. Pharmaceutics 2020; 12: 694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Al Kaisy GM, Mutalib MIA, Leveque JM, Rao TVVLN. Novel low viscosity ammonium-based ionic liquids with carboxylate anions: Synthesis, characterization, and thermophysical properties. J Mol Liq 2017; 230: 565–573. [Google Scholar]
  • 13.Tan Z-Q, Liu J-F, Pang L. Advances in analytical chemistry using the unique properties of ionic liquids. TrAC Trends Anal Chem 2012; 39: 218–227. [Google Scholar]
  • 14.Yan J, Zhu Y, Hu G, Liang Q, Ge L, Yang K. Chiral quaternary ammonium ionic liquids derived from natural dehydroabietylamine and their potential application in chiral molecular recognition. Tetrahedron 2023; 130: 133165. [Google Scholar]
  • 15.Costa FM, Saraiva ML, Passos ML. Ionic liquids and organic salts with antimicrobial activity as a strategy against resistant microorganisms. J Mol Liq 2022; 368: 120750. [Google Scholar]
  • 16.Reddy GKK, Nancharaiah YV. Alkylimidazolium ionic liquids as antifungal alternatives: antibiofilm activity against Candida albicans and underlying mechanism of action. Front Microbiol 2020; 11: 730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Maheronnaghsh M, Teimoori A, Dehghan P, Fatahinia M. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis. J Clin Lab Anal 2022; 36(2): e24208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yang Y-J, Liu Y, Liu D-D, Guo W-Z, Wang L-X, Wang X-J, et al. Development of a flow cytometry-based plating-free system for strain engineering in industrial fungi. Appl Microbiol Biotechnol 2022; 106: 713–727. [DOI] [PubMed] [Google Scholar]
  • 19.Singh SK, Savoy AW. Ionic liquids synthesis and applications: An overview. J Mol Liq 2020; 297: 112038. [Google Scholar]
  • 20.Venkata Nancharaiah Y, Reddy GK, Lalithamanasa P, Venugopalan VP. The ionic liquid 1-alkyl-3-methylimidazolium demonstrates comparable antimicrobial and antibiofilm behavior to a cationic surfactant. Biofouling 2012; 28: 1141–1149. [DOI] [PubMed] [Google Scholar]
  • 21.Černáková L, Líšková A, Lengyelová L, Rodrigues CF. Prevalence and antifungal susceptibility profile of oral Candida spp. Isolates from a Hospital in Slovakia. Medicina (Kaunas) 2022; 58: 576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Suchodolski J, Feder-Kubis J, Krasowska A. Antiadhesive properties of imidazolium ionic liquids based on (−)-Menthol against Candida spp. Int J Mol Sci 2021; 22: 7543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jampilek J. Novel avenues for identification of new antifungal drugs and current challenges. Expert Opin Drug Discov 2022; 17: 949–968. [DOI] [PubMed] [Google Scholar]
  • 24.Gong Y, Yin S, Sun S, Li M. Chelerythrine reverses the drug resistance of resistant Candida albicans and the biofilm to fluconazole. Future Microbiol 2022; 17: 1325–1333. [DOI] [PubMed] [Google Scholar]
  • 25.Agrawal D, Patterson T, Rinaldi M, Revankar S. Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature. J Med Microbiol 2007; 56: 1003–1004. [DOI] [PubMed] [Google Scholar]
  • 26.Braga-Silva LA, Mesquita DG, Ribeiro MD, Carvalho SM, Fracalanzza SE, Santos AL. Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases. Braz J Med Biol Res 2009; 42: 765–770. [DOI] [PubMed] [Google Scholar]
  • 27.Kaur J, Nobile CJ. Antifungal drug-resistance mechanisms in Candida biofilms. Curr Opin Microbiol 2023; 71: 102237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Stevens DA, Espiritu M, Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 2004; 48: 3407–3411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.De Jong AW, Van Veldhuizen D, Groot AT, Hagen F. Standardized methods to rear high-quality Galleria mellonella larvae for the study of fungal pathogens. Entomol Exp Appl 2022; 170: 1073–1080. [Google Scholar]
  • 30.Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A. Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob Agents Chemother 2004; 48: 2477–2482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lima A, Widen R, Vestal G, Uy D, Silbert S. A TaqMan probe-based real-time PCR assay for the rapid identification of the emerging multidrug-resistant pathogen Candida auris on the BD Max system. J Clin Microbiol 2019; 57(7): e01604–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Simões M, Pereira AR, Simões LC, Cagide F, Borges F. Biofilm control by ionic liquids. Drug Discov Today 2021; 26: 1340–1346. [DOI] [PubMed] [Google Scholar]
  • 33.Reddy GKK, Nancharaiah YV. Alkylimidazolium ionic liquids as antifungal alternatives: antibiofilm activity against Candida albicans and underlying mechanism of action. Front Microbiol 2020; 11: 730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Schrekker CM, Sokolovicz YC, Raucci MG, Selukar BS, Klitzke JS, Lopes W, et al. Multitask imidazolium salt additives for innovative poly (l-lactide) biomaterials: morphology control, Candida spp. biofilm inhibition, human mesenchymal stem cell biocompatibility, and skin tolerance. ACS Appl Mater Interfaces 2016; 8: 21163–21176. [DOI] [PubMed] [Google Scholar]
  • 35.Guo H-Y, Cao B, Deng G, Hao X-L, Wu F-G, Yu Z-W. Effect of imidazolium-based ionic liquids on the structure and phase behavior of palmitoyl-oleoyl-phosphati-dylethanolamine. J Phys Chem B 2019; 123: 5474–5482. [DOI] [PubMed] [Google Scholar]
  • 36.Takamuku T, Hoke H, Idrissi A, Marekha BA, Moreau M, Honda Y, et al. Microscopic interactions of the imidazolium-based ionic liquid with molecular liquids depending on their electron-donicity. Phys Chem Chem Phys 2014; 16: 23627–23638. [DOI] [PubMed] [Google Scholar]
  • 37.Kiran Kumar Reddy G, Nancharaiah YV. Alkylimidazolium ionic liquids for biofilm control: Experimental studies on controlling multispecies biofilms in natural waters. J Mol Liq 2021; 336: 116859. [Google Scholar]
  • 38.Li Y, Yang F, Li Y, Cai M, Li H, Fan X, et al. Choline amino acid ionic liquids: A novel green potential lubricant. J Mol Liq 2022; 360: 119539. [Google Scholar]
  • 39.Michalski J, Odrzygóźdź C, Mester P, Narożna D, Cłapa T. Defeat undefeatable: ionic liquids as novel antimicrobial agents. J Mol Liq 2023; 369: 120782. [Google Scholar]
  • 40.Dimitrić N, Spremo N, Vraneš M, Belić S, Karaman M, Kovačević S, et al. New protic ionic liquids for fungi and bacteria removal from paper heritage artefacts. RSC Adv 2019; 9: 17905–17912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Yang DD, Paterna NJ, Senetra AS, Casey KR, Trieu PD, Caputo GA, et al. Synergistic interactions of ionic liquids and antimicrobials improve drug efficacy. iScience 2021; 24: 101853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chen LM, Xu YH, Zhou CL, Zhao J, Li CY, Wang R. Overexpression of CDR1 and CDR2 Genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C Mutations. J Int Med Res 2010; 38: 536–545. [DOI] [PubMed] [Google Scholar]
  • 43.Suchodolski J, Krasowska A. Fructose induces fluconazole resistance in Candida albicans through activation of Mdr1 and CDR1 transporters. Int J Mol Sci 2021; 22: 2127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Borgeat V, Brandalise D, Grenouillet F, Sanglard D. Participation of the ABC Transporter CDR1 in Azole Resistance of Candida lusitaniae. J Fungi (Basel) 2021; 7: 760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Shao J, Zhang M, Wang T, Li Y, Wang C. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans. Pharm Biol 2016; 54: 984–992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Valli M, Sauer M, Branduardi P, Borth N, Porro D, Mattanovich D. Intracellular pH distribution in Saccharomyces cerevisiae cell populations, analyzed by flow cytometry. Appl Environ Microbiol 2005; 71: 1515–1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hernlem B, Hua S-S. Dual fluorochrome flow cytometric assessment of yeast viability. Curr Microbiol 2010; 61: 57–63. [DOI] [PubMed] [Google Scholar]
  • 48.Cook K, Tarnawsky K, Swinton AJ, Yang DD, Senetra AS, Caputo GA, et al. Correlating lipid membrane permeabilities of imidazolium ionic liquids with their cytotoxicities on yeast, bacterial, and mammalian cells. Biomolecules 2019; 9: 251. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Iranian Journal of Microbiology are provided here courtesy of Tehran University of Medical Sciences

RESOURCES